Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice

Fig. 7

a In vivo anti-tumoral outcomes Assessed by tumor size growth evaluation. Although the variation in tumor size between groups is obvious, this variation is not statistically significant. b The mice's weight was assessed following treatments. In both Msc-Reo and Msc-Reo-nT groups increasing weight has shown a slow trend compared to other groups. After the final treatment, the control group (Pbs) showed increased weight because tumor growth was raised. The diagram was determined by the mean weight of each group. c In vivo anti-tumoral response in the 1st and final sacrifice times depicted by tumor sizes. In 3 (after first treatment) and 13 days (after all treatments) after the first treatments three mice from each group randomly were sacrificed and tumor isolated for more investigation. d The time course of the whole project was depicted in d. The time of I.V treatments and sacrificed turns indicated by arrows.

Back to article page